Enhance Your Connected eSource Ecosystem With Mixed-Modality-Capable Lunexis ePRO+
Electronic Source Data Collection and Management Methods for Clinical Research
Streamline your clinical trials with more than fast, clean data — now gain even greater operational speed and efficiency with the configurable Lunexis™ Ecosystem. Deploy our holistic eSource platform, paired with adjacent best-in-breed technologies to achieve a better trial experience for everyone — with 3x-faster study builds.
As the pioneers in eSource, we know our solutions must fit patients’ and sites’ day-to-day realities. Lunexis ePRO+ enhancements provide the adaptability to support clinical trial patients and their physicians in today’s unpredictable world.
The more seamlessly your clinical trial fits into your patient’s life, the more likely your patient is to stay engaged. That’s why our implementation options support patients at home or at the clinic, on personal or provisioned devices. Today more than ever, Lunexis excels in supporting any decentralized or traditional model in any therapeutic area your protocol demands.
The latest ePRO+ enhancements will take you from protocol to a simplified, patient-centric solution in less time, allowing you to:
Offer Patients and Sites More Options With Mixed Deployment Modalities
Patients using ePRO and site personnel using ePRO, ClinRO, or direct data capture (DDC) can switch back and forth between modalities — and locations — to suit their own needs. For ePRO, patients and sites can use provisioned or BYOD smartphones, PCs, or both; ClinRO and DDC may be executed on tablets, PCs, or both; and trials may be performed at virtual and/or physical locations, supporting hybrid trial designs.
Achieve Greater Operational Speed and Efficiency
The only purpose-built platform compatible with any trial design, the Lunexis platform is a highly configurable eSource ecosystem. Streamline your clinical trials with more than fast, clean data. Our holistic eSource platform, featuring high-efficiency ePRO and ClinRO technologies, delivers a better trial experience for sites, patients, and sponsors — and 3x-faster study builds.
No Need for Validation Enables Real-Time Decision Making
Data entered directly into the digital record during the patient visit, as it is with our eSource technology, does not require validation. What this means for clients is near-immediate accessibility, rapid query resolution, time savings, and valuable mid-trial decision-making capability.
Deploy ePRO Quickly With Rapid Study Builds
Custom ePRO software can be time consuming and labor intensive to deploy. However, you can enlist Clinical Ink’s experienced team to take care of Lunexis ePRO+ configuration, eliminating custom coding, and enabling extremely rapid study builds.
Unified Authoring Simplifies Mixed-Modality Applications
Clinical Ink project teams and ePRO/eCOA experts design, configure, and deploy prototypes for sponsor and CRO design reviews. Once complete, each design can be applied across the spectrum of modalities with ease. Once approved, designs are saved to customer-specific libraries, allowing for their rapid reuse. This approach accelerates complex document reviews and improves efficiency and quality of sponsor feedback.
Be Ready With Insight Into Patient Compliance
Not surprisingly, our unified ePRO+ platform produces a single report that registers site and patient activities. Sites and monitors can then engage with patients proactively to encourage further compliance, as needed. Lunexis can deploy compliance email alerts for site staff and push notifications on patient smartphones.
Engage Patients Even Better With BYOD
Lunexis ePRO+ smartphone solutions allow you to engage with patients and keep them connected, particularly at crucial moments during their clinical trials. Our platform improves questionnaire compliance, visit attendance, and medication adherence. BYOD saves time, lowers cost, and improves questionnaire compliance when used with a myriad of on-site eCOA solutions.
Navigate Complex Therapeutic Areas
In certain therapeutic areas with complex trials, ePRO data is especially important. Our special applications developed in consultation with clinical specialists facilitate study conduct. We produce Lunexis ePRO+ applications purpose-built for lupus, GI, CNS (pain/migraine), infectious disease, dermatology, oncology, and a variety of others.
Treat Your Team to Painless Training
In our latest ePRO offering, we have implemented first-in-class interactive training tools. Train on just the features you need, when you need them. Your team will breeze through training and actually retain what they have learned with our engaging in-app walkthroughs and practice, helpful resources, and live chat.
Imagine a single technology that empowers sites and patients with an easier, more positive clinical trial experience and flexes to support you from protocol development to commercialization. Make it a reality with Clinical Ink.
The Lunexis™ eSource Ecosystem streamlines processes and optimizes patient and site performance through a flexible, unified platform compatible with any trial design. It integrates mixed modalities: ePRO via smartphone — provisioned or BYOD, web, or both; ClinRO and DDC by tablet, web, or both; and sites — decentralized and traditional. With more options for greater convenience, patients have a more pleasant journey, stay engaged, and contribute more complete data.
How Will Your Patient’s Data Stream and Your Work Flow?
Here’s One Possible Reality.